We are currently developing a novel gene therapy approach targeting ischemic and rare genetic cardiac diseases, and moving from lab preclinical trials to regulatory trials.
The Company was founded in October and has received strong traction since inception.
We will be looking to strengthen our human and financial ressources in the coming month in order to start the regulatory pre clinical trials.
Company Details
- Founded
- -
- Address
- La Ciotat, Fr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://neocor.fr
- HQ
- La Ciotat
Neocor Therapeutics Questions
Neocor Therapeutics's website is https://neocor.fr
Neocor Therapeutics's LinkedIn profile is https://fr.linkedin.com/company/neocor-therapeutics
Neocor Therapeutics's industry is
Biotechnology Research
Neocor Therapeutics's top competitors are
Prologia,
Vrai-Heart,
Pmb-Alcen,
Neurodyx Therapeutics,
Ispiron Biotechnologies,
Xantial - Digital Therapeutics (Dtx),
Cytobodx,
Eurobiomed,
Phenocell (Axol Bioscience Ltd.),
Ana Healthcare.
Neocor Therapeutics's categories are Biotechnology Research
Neocor Therapeutics's founding year is 2023
